Nessa Carey and Xand Van Tulleken on How Gene Editing Will Rewrite Our Futures
Intelligence Squared
00:00
Genetic Testing and Sickle Cell Treatment Innovations
This chapter explores the ethical implications of genetic testing in health insurance, focusing on potential discrimination and future scenarios with genetic alterations for coverage. It also examines innovative gene editing technologies in clinical trials for sickle cell disease, emphasizing the use of patients' own bone marrow to develop effective treatments and improve patient outcomes.
Transcript
Play full episode
